TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 151 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,608 | -23.1% | 16,511 | +32.0% | 0.00% | 0.0% |
| Q2 2023 | $192,061 | -30.6% | 12,504 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $276,874 | +39.6% | 12,311 | +30.5% | 0.00% | 0.0% |
| Q4 2022 | $198,355 | +7.2% | 9,432 | +25.7% | 0.00% | 0.0% |
| Q3 2022 | $185,000 | +1.6% | 7,504 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $182,000 | -26.9% | 7,504 | -22.4% | 0.00% | 0.0% |
| Q1 2022 | $249,000 | -25.0% | 9,673 | -9.5% | 0.00% | -50.0% |
| Q4 2021 | $332,000 | +78.5% | 10,686 | +39.1% | 0.00% | +100.0% |
| Q3 2021 | $186,000 | +66.1% | 7,680 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $112,000 | -40.7% | 7,676 | +1.2% | 0.00% | 0.0% |
| Q1 2021 | $189,000 | -10.4% | 7,587 | -1.9% | 0.00% | 0.0% |
| Q4 2020 | $211,000 | – | 7,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |